Total Payments
$5,979
2024 Payments
$1,258
Companies
37
Transactions
340
Medicare Patients
5,223
Medicare Billing
$489,230
Payment Breakdown by Category
Food & Beverage$5,935 (99.3%)
Education$43.83 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,935 | 338 | 99.3% |
| Education | $43.83 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,327 | 91 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $831.96 | 43 | $0 (2024) |
| ABBVIE INC. | $756.21 | 45 | $0 (2024) |
| Lilly USA, LLC | $609.31 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $378.33 | 19 | $0 (2022) |
| GlaxoSmithKline, LLC. | $234.78 | 11 | $0 (2024) |
| PFIZER INC. | $208.36 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $202.11 | 11 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $175.03 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $133.40 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,258 | 61 | Novo Nordisk Inc ($371.32) |
| 2023 | $1,141 | 63 | Novo Nordisk Inc ($294.53) |
| 2022 | $1,076 | 74 | Novo Nordisk Inc ($295.49) |
| 2021 | $777.18 | 48 | AbbVie Inc. ($222.65) |
| 2020 | $746.28 | 41 | Janssen Pharmaceuticals, Inc ($260.09) |
| 2019 | $631.75 | 36 | AstraZeneca Pharmaceuticals LP ($319.40) |
| 2018 | $177.07 | 7 | AstraZeneca Pharmaceuticals LP ($140.39) |
| 2017 | $171.52 | 10 | AstraZeneca Pharmaceuticals LP ($36.42) |
All Payment Transactions
340 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/27/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Gastroenterology | ||||||
| 10/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.44 | General |
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.79 | General |
| 08/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.96 | General |
| 07/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,190 | 1,463 | $289,590 | $137,130 |
| 2022 | 19 | 1,296 | 1,524 | $262,740 | $122,412 |
| 2021 | 22 | 1,461 | 1,736 | $270,905 | $132,204 |
| 2020 | 18 | 1,276 | 1,627 | $230,120 | $97,484 |
Total Patients
5,223
Total Services
6,350
Medicare Billing
$489,230
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 223 | 245 | $67,375 | $31,282 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 311 | $77,750 | $30,718 | 39.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 195 | 195 | $43,875 | $26,709 | 60.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 243 | $42,525 | $16,693 | 39.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 37 | 45 | $18,000 | $7,605 | 42.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 74 | 75 | $5,990 | $5,381 | 89.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $5,950 | $4,795 | 80.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 16 | $6,800 | $3,749 | 55.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $5,850 | $2,958 | 50.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 80 | 81 | $2,990 | $2,545 | 85.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,300 | $1,359 | 41.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 91 | 107 | $2,140 | $891.09 | 41.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 17 | $1,870 | $749.53 | 40.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $950.00 | $614.08 | 64.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 49 | 50 | $3,250 | $585.62 | 18.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 13 | $975.00 | $497.52 | 51.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 211 | 234 | $64,350 | $31,250 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 269 | $67,050 | $26,492 | 39.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 162 | 162 | $36,450 | $22,540 | 61.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 147 | 224 | $39,200 | $14,645 | 37.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 73 | 73 | $7,300 | $4,997 | 68.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 19 | $8,075 | $4,523 | 56.0% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 76 | 76 | $6,575 | $3,103 | 47.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $5,200 | $2,665 | 51.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 84 | 84 | $2,520 | $2,473 | 98.1% |
About Dr. Jeffrey Grinblatt, MD
Dr. Jeffrey Grinblatt, MD is a Internal Medicine healthcare provider based in Skokie, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679580039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Grinblatt, MD has received a total of $5,979 in payments from pharmaceutical and medical device companies, with $1,258 received in 2024. These payments were reported across 340 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($5,935).
As a Medicare-enrolled provider, Grinblatt has provided services to 5,223 Medicare beneficiaries, totaling 6,350 services with total Medicare billing of $489,230. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Skokie, IL
- Active Since 08/01/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679580039
Products in Payments
- FARXIGA (Drug) $654.78
- VRAYLAR (Drug) $521.77
- Ozempic (Drug) $499.28
- MOUNJARO (Drug) $372.45
- XARELTO (Drug) $366.06
- Rybelsus (Drug) $332.10
- JARDIANCE (Drug) $242.80
- Kerendia (Drug) $175.03
- Wegovy (Drug) $165.10
- UBRELVY (Drug) $126.10
- Dexcom G6 Transmitter (Medical Supply) $105.82
- SYMBICORT (Drug) $99.52
- ELIQUIS (Drug) $90.08
- VIBERZI (Drug) $84.51
- ENTRESTO (Drug) $77.57
- SHINGRIX (Biological) $70.89
- AREXVY (Drug) $70.80
- Cologuard Collection Kit (Device) $67.73
- TRELEGY ELLIPTA (Drug) $65.04
- NURTEC ODT (Drug) $56.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Skokie
Liana Billings, Md, Mmsc, MD, MMSC
Internal Medicine — Payments: $387,410
Internal Medicine $387,410
Gregory Mishkel, M.d, M.D
Internal Medicine — Payments: $61,716
Internal Medicine $61,716
Greg Denenberg, Md, MD
Internal Medicine — Payments: $25,547
Internal Medicine $25,547
Dr. Stephen Kashian, Md, MD
Internal Medicine — Payments: $23,403
Internal Medicine $23,403
Dr. Cliff Ireland, D.o, D.O
Internal Medicine — Payments: $22,598
Internal Medicine $22,598
Dr. Gregory Kaczmarek, Md, MD
Internal Medicine — Payments: $22,496
Internal Medicine $22,496